Jonjobot-

It's very interesting that the title has been changed - unusual in my experience.

I'm also curious that while it has been done with the aim of highlighting the benefits of ABL for CVD in CKD patients, there is no reference to changes in kidney function.

Is that because of the embargo?

I'd be interested to see the titles of other presentations but don't have the link to the session.